- Home
- EPOW vs RVPH Comparison
EPOW vs RVPH Comparison
Compare EPOW & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- RVPH
- Stock Information
- Founded
- EPOW 2014
- RVPH 2006
- Country
- EPOW China
- RVPH United States
- Employees
- EPOW N/A
- RVPH N/A
- Industry
- EPOW Business Services
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- EPOW Consumer Discretionary
- RVPH Health Care
- Exchange
- EPOW Nasdaq
- RVPH Nasdaq
- Market Cap
- EPOW 24.5M
- RVPH 32.8M
- IPO Year
- EPOW 2021
- RVPH N/A
- Fundamental
- Price
- EPOW $0.98
- RVPH $0.40
- Analyst Decision
- EPOW
- RVPH Strong Buy
- Analyst Count
- EPOW 0
- RVPH 5
- Target Price
- EPOW N/A
- RVPH $9.00
- AVG Volume (30 Days)
- EPOW 17.7K
- RVPH 3.4M
- Earning Date
- EPOW 07-22-2025
- RVPH 08-13-2025
- Dividend Yield
- EPOW N/A
- RVPH N/A
- EPS Growth
- EPOW N/A
- RVPH N/A
- EPS
- EPOW N/A
- RVPH N/A
- Revenue
- EPOW $64,997,741.00
- RVPH N/A
- Revenue This Year
- EPOW N/A
- RVPH N/A
- Revenue Next Year
- EPOW N/A
- RVPH N/A
- P/E Ratio
- EPOW N/A
- RVPH N/A
- Revenue Growth
- EPOW 44.28
- RVPH N/A
- 52 Week Low
- EPOW $0.55
- RVPH $0.30
- 52 Week High
- EPOW $1.36
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- EPOW 54.02
- RVPH 33.44
- Support Level
- EPOW $0.92
- RVPH $0.35
- Resistance Level
- EPOW $0.96
- RVPH $0.83
- Average True Range (ATR)
- EPOW 0.06
- RVPH 0.06
- MACD
- EPOW 0.01
- RVPH -0.01
- Stochastic Oscillator
- EPOW 62.50
- RVPH 17.36
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.